These observations align with prior evidence linking BPA, a well-known EDC, to estrogen-dependent malignancies such as estrogen receptor-positive breast cancer, endometrial cancer type 1, and selected subtypes of ovarian cancer, such as low-grade serous and endometrioid tumors [11,18,19,20,21,22]. This evidence concerns the gene ESR1 and ovarian cancer.